Community-Based Multi-Site Randomized Controlled Trial of Behavioral Activation for Patients with Depressive Disorders
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eunbyeol | - |
dc.contributor.author | Han, Yeoul | - |
dc.contributor.author | Cha, Yun Ji | - |
dc.contributor.author | Oh, Ji-Hye | - |
dc.contributor.author | Hwang, Na-Ri | - |
dc.contributor.author | Seo, Ho-Jun | - |
dc.contributor.author | Choi, Kee-Hong | - |
dc.date.accessioned | 2022-02-11T15:41:12Z | - |
dc.date.available | 2022-02-11T15:41:12Z | - |
dc.date.created | 2022-02-09 | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0010-3853 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/135354 | - |
dc.description.abstract | Behavioral activation (BA) is a beneficial and relatively cost-effective treatment option for depression. This study utilized a pragmatic randomized controlled research design to investigate whether BA, as compared with treatment as usual (TAU), led to superior treatment effects, when delivered in community mental health settings by retrained community mental health professionals. Patients with depressive disorders (n = 64) were randomly assigned to a 10-session BA (n = 31) or TAU (n = 33) group. The depressive symptoms and behavioral engagement were assessed at the baseline, post-treatment, and a six-month follow-up. Results showed that, as compared to the TAU group, the BA group had: (1) a reduction in depression severity, as evidenced by large effect sizes and greater response rates, and (2) an increase in behavioral engagement. However, the post-treatment gains were not maintained at the six-month follow-up. The implications and limitations of the study are also discussed (KCT0004098, June 27, 2019, retrospectively registered). | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.title | Community-Based Multi-Site Randomized Controlled Trial of Behavioral Activation for Patients with Depressive Disorders | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Kee-Hong | - |
dc.identifier.doi | 10.1007/s10597-021-00828-3 | - |
dc.identifier.scopusid | 2-s2.0-85104846939 | - |
dc.identifier.wosid | 000640825000001 | - |
dc.identifier.bibliographicCitation | COMMUNITY MENTAL HEALTH JOURNAL, v.58, no.2, pp.343 - 355 | - |
dc.relation.isPartOf | COMMUNITY MENTAL HEALTH JOURNAL | - |
dc.citation.title | COMMUNITY MENTAL HEALTH JOURNAL | - |
dc.citation.volume | 58 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 343 | - |
dc.citation.endPage | 355 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalResearchArea | Public, Environmental & Occupational Health | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Health Policy & Services | - |
dc.relation.journalWebOfScienceCategory | Public, Environmental & Occupational Health | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | ANTIDEPRESSANT MEDICATION | - |
dc.subject.keywordPlus | COGNITIVE THERAPY | - |
dc.subject.keywordPlus | PROGRAM | - |
dc.subject.keywordPlus | ADULTS | - |
dc.subject.keywordPlus | SCALE | - |
dc.subject.keywordAuthor | Depression | - |
dc.subject.keywordAuthor | Behavioral activation | - |
dc.subject.keywordAuthor | Randomized controlled trial | - |
dc.subject.keywordAuthor | Community mental health services | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.